• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 19
12:00 pm - 1:00 pm CST

Les Turner ALS Foundation Webinar: The Caregiver’s Journey

Nov 20
7:45 am - 5:15 pm MST

Canadian Society of Palliative Medicine: Palliative Horizons – Clinical Approaches to ALS and Parkinson’s

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Daniel Hare, USA

    Daniel Hare, USA

  • John Russo, USA

    John Russo, USA
    final3878

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Frank Taylor, USA

    Frank Taylor, USA

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Purningam Jacob, India

    Purningam Jacob, India

  • Yessenia Hernandez Mendoza, Mexico

    Yessenia Hernandez Mendoza, Mexico

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Jon Newsome, USA

    Jon Newsome, USA

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Anna Barrow, UK

    Anna Barrow, UK

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Susan Keldani, USA

    Susan Keldani, USA

  • Liam Dwyer, England

    Liam Dwyer, England

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • David Watson, Scotland

    David Watson, Scotland

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • Jason Goodman, USA

    Jason Goodman, USA

  • Zabun Nassar, England

    Zabun Nassar, England

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Rosie Riley, USA

    Rosie Riley, USA

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login